Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report kdunleavy Wed, 11/06/2024 – 09:23 More: Drugs for unmet needs and those from experienced companies had the best chance for successful
read more
Phase 1 and 2 studies show promising results for anito-cel therapy More: Arcellx to present positive data on multiple myeloma treatments Source: News
read more
New therapy targets specific genetic alterations, promises extended survival More: MHRA grants approval for bladder cancer drug erdafitinib Source: News
read moreAnalysts point to Syfovre ‘nadir’ after Apellis discloses disappointing quarter fkansteiner Tue, 11/05/2024 – 15:00 More: Analysts point to Syfovre 'nadir' after Apellis discloses disappointing quarter Source: fierce
read moreAstraZeneca stock tanks over fears of expanding China fraud probe aliu Tue, 11/05/2024 – 14:47 More: AstraZeneca stock tanks over fears of expanding China fraud probe Source: fierce
read moreVertex’s Casgevy breaks ground with 1st commercial patient infusions as company readies another major launch for 2025 zbecker Tue, 11/05/2024 – 11:27 More: Vertex's Casgevy breaks ground with 1st commercial patient infusions as company readies another major launch for 2025
read more© 1994 - 2025 B.M. Pharmaceuticals